These free online tools let you skip the setup and start tracking your money right away. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...
This gave Incyte exclusive global rights to tafasitamab, a humanized Fc-modified CD19-targeting immunotherapy marketed in the United States (as Monjuvi) and outside the country (as Minjuvi).
一些您可能无法访问的结果已被隐去。
显示无法访问的结果